An Open Label Study to Evaluate Cycle Control With Ortho Tri-Cyclen Lo (Norgestimate/Ethinyl Estradiol) and Yaz (Drospirenone/Ethinyl Estradiol) in Healthy Sexually Active Females.

Trial Profile

An Open Label Study to Evaluate Cycle Control With Ortho Tri-Cyclen Lo (Norgestimate/Ethinyl Estradiol) and Yaz (Drospirenone/Ethinyl Estradiol) in Healthy Sexually Active Females.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Jun 2011

At a glance

  • Drugs Ethinylestradiol/norgestimate (Primary) ; Drospirenone/ethinylestradiol
  • Indications Pregnancy
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Dec 2009 Primary endpoint 'Menstrual bleeding' has been met.
    • 01 Dec 2009 Results published in Obstetrics and Gynecology.
    • 06 May 2009 Results presented at ACOG 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top